Grifols | GRFS - L'Utile Operativo





L'Utile Operativo Cambiamento Data
Alaunos Therapeutics USD -1.19M 432K 2025-09
Arca Biopharma USD -25.09M 5.23M 2025-03
aTyr Pharma USD -26.74M 6.43M 2025-09
Bio Path USD -3.24M 616K 2025-03
Brainstorm Cell Therapeutics USD -3.09M 100K 2025-03
Capricor Therapeutics USD -24.98M 17.28M 2025-03
Cara Therapeutics USD -2.39M 3.49M 2025-03
Esperion Therapeutics USD 85.23M 95.19M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Grifols EUR 411.56M 15.51M 2025-09
Immunic USD -25.73M 2.91M 2024-09
Infinity Pharmaceuticals USD -10.12M 1.39M 2023-06
Minerva Neurosciences USD -21.85M 17.48M 2024-12
Nektar Therapeutics USD -34.34M 15.43M 2024-09
Sangamo BioSciences USD -33.51M 12.77M 2024-06
TherapeuticsMD USD -1.18M 40K 2024-06